The time course of topical PUVA erythema following 15- and 5-minute methoxsalen immersion

Archives of Dermatology

Volumn 139, Issue 3, 2003, Pages 331-334

  Man, Irene ^a   Kwok, Yew Kai ^a   Dawe, Robert S ^a   Ferguson, James ^a   Ibbotson, Sally H ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXSALEN;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; IMMERSION; MALE; PHOTOTHERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PSORIASIS; PUVA; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ERYTHEMA; FEMALE; HUMANS; IMMERSION; MALE; METHOXSALEN; MIDDLE AGED; PHOTOSENSITIZING AGENTS; PUVA THERAPY; RADIOMETRY; REFERENCE VALUES; TIME FACTORS;

EID: 0037341130     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.3.331     Document Type: Article

References (18)

1. Halpern SM, Anstey A, Dawe RS, et al. Guidelines for topical PUVA: a report of a workshop of the British Photodermatology Group. Br J Dermatol. 2000;142:22-31.
2. Lowe NJ, Weingarten D, Bourget T, May LS. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoraten. J Am Aced Dermatol, 1986;14:754-760.
3. British Photodermatology Group. British Photodermatology Group guidelines for PUVA. Br J Dermatol, 1994;130:246-255.
4. Fitzpatrick TB, Hopkins CE, Blickenstaff DD, Swift S. Augmented pigmentation and other responses of normal human skin to solar radiation following oral administration of B-methoxypsoralen. J Invest Dermatol, 1955;25:187-190.
5. Parrish JA. Melhoxsalen-UV-A therapy of psoriasis. J Invest Dernatol. 1976;67: 669-671.
6. Gupta AK, Anderson TF. Psoralen phatochemotherapy. J Am Acad Dematol 1987; 17:703-734.
7. Frain-Bell W. Treatment. In: Frain-Bell, Cutaneous Photobiology. Oxford, England: Oxford University Press; 1985:170-202.
8. Pathak MA, Fitzpatrick TB, Parrish JA, Pharmacologic and molecular aspects of psoralen photochemotherapy. In: Farber EM, Cox AJ, ads. Psoriasis: Proceedings of the Second International Symposium. New York, NY: Yorke Medical Books; 1976:262-271.
9. Ibbotson SH, Farr PM. The time-course of psoralen ultraviolet A (PUVA) erythema. J Invest Dermetol 1999;113:346-350.
10. Behrens-Williams S, Gruss C, Grundmann-Kollmann M, Peter RU, Kerscher M. Assessment of minimal phototoxic dose following B-methoxypsoralen bath: maximal reaction on average after 5 days. Br J Dermatol. 2000;142:112-115.
11. Grundmann-Kollmann M, Leiter U, Behrens S, Gottlober P, Mooser G, Krahn G, Kerscher M. The time course of phototoxicity of topical PUVA: B-methoxypsoralen cream-PUVA vs B-methoxypsoralen gel-PUVA. Br J Dermatol 1999;140: 988-990.
12. Murphy R, Thomas SE, Bothwell JE. Five-minute soak times for the delivery of bath B-MOP in the treatment of psoriasis [abstract]. Br J Dermatol. 2000;143 (suppl 57):73.
13. Diffey BL, Oliver RJ, Farr PM. A portable instrument for quantifying erythema induced by ultraviolet radiation. Br J Dermatol 1984;111:663-672.
14. Diffey BL, Farr PM. Quantitative aspects of ultraviolet erythema. Clin Phys Physiol Meas, 1991;12:311-325.
15. Davidson A. Calculation of erythema dose-response curves using a spreadsheet. Photodermatol Photo Immunol Photomed. 1999;15:104-108.
16. Sakuntabhai A, Sharp GR, Farr PM. Response of psoriasis to twice weekly PUVA. Br J Dermatol. 1993;126:166-171.
17. Azurdia RM, Dean MP, Rhodes LE. Reduction in B-methoxypsoralen immersion time alters the erythemal response to bath PUVA. Photodermatol Photoimmunol Photomed. 2000;16:186-188.
18. Dolezal E, Seeber A, Hönigsmann H, Tanew A. Correlation between bathing time and photosensitivity in B-methoxypsoralen (B-MOP) bath PUVA. Photodermatol Photoimmunol Photomed. 2000;16:183-185.